Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Dominion Aesthetic Technologies has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Non Invasive Device Solution Companies - 2020,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Janet Campbell, CEO and Chairman of the Board.
Janet Campbell, CEO and Chairman of the Board
Company
Dominion Aesthetic Technologies
Management
Janet Campbell, CEO and Chairman of the Board
Description
A Texas-based medical devices company, Dominion Aesthetic Technologies has developed eon, the world’s first non-contact laser device which is FDA-cleared for abdominal fat reduction and designed with several unique features. In contrast with other energy-based treatments for fat reduction, eon has a novel and highly effective cooling system that maintains patient comfort while the laser reduces the unwanted fat tissue. The device works by inducing apoptosis, a process that gently kills the fat cells, which are eliminated through the lymphatic system and normal urination
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
